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Abstract
Background: Malaria afflicts 300–500 million people causing over 1 million deaths globally per
year. The immunopathogenesis of malaria is mediated partly by co mplex cellular and
immunomodulator interactions involving co-regulators such as cytokines and adhesion molecules.
However, the role of chemokines and their receptors in malaria immunopathology remains
unclear. RANTES (Regulated on Activation Normal T-Cell Expressed and Secreted) is a chemokine
involved in the generation of inflammatory infiltrates. Recent studies indicate that the degradation
of cell-cell junctions, blood-brain barrier dysfunction, recruitment of leukocytes and Plasmodium-
infected erythrocytes into and occlusion of microvessels relevant to malaria pathogenesis are
associated with RANTES expression. Additionally, activated lymphocytes, platelets and endothelial
cells release large quantities of RANTES, thus suggesting a unique role for RANTES in the
generation and maintenance of the malaria-induced inflammatory response. The hypothesis of this
study is that RANTES and its corresponding receptors (CCR1, CCR3 and CCR5) modulate malaria
immunopathogenesis. A murine malaria model was utilized to evaluate the role of this chemokine
and its receptors in malaria.
Methods: The alterations in immunomodulator gene expression in brains of Plasmodium yoelii
17XL-infected mice was analysed using cDNA microarray screening, followed by a temporal
comparison of mRNA and protein expression of RANTES and its corresponding receptors by qRT-
PCR and Western blot analysis, respectively. Plasma RANTES levels was determined by ELISA and
ultrastructural studies of brain sections from infected and uninfected mice was conducted.
Results: RANTES (p < 0.002), CCR1 (p < 0.036), CCR3 (p < 0.033), and CCR5 (p < 0.026) mRNA
were significantly upregulated at peak parasitaemia and remained high thereafter in the
experimental mouse model. RANTES protein in the brain of infected mice was upregulated (p <
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0.034) compared with controls. RANTES plasma levels were significantly upregulated; two to three
fold in infected mice compared with controls (p < 0.026). Some d istal microvascular endothelium
in infected cerebellum appeared degraded, but remained intact in controls.
Conclusion:  The upregulation of RANTES, CCR1, CCR3, and CCR5 mRNA, and RANTES
protein mediate inflammation and cellular degradation in the cerebellum during P. yoelii 17XL
malaria.
Background
Malaria afflicts between 300–500 million people causing
up to 2 million deaths globally per year [1]. Cerebral
malaria (CM), characterized by seizures and loss of con-
sciousness, is the most severe complication of Plasmodium
falciparum infection with mortality rates ranging from 15
to 20% [2,3]. Malaria-induced brain inflammation is
known to be mediated partly by complex cellular and
immunomodulator interactions, involving co-regulators
such as cytokines and adhesion molecules, resulting in the
sequestration of parasite-infected erythrocytes in the brain
in human CM. Apart from the sequestration of P. falci-
parum-infected erythrocytes, recent studies [4-7] have
revealed significant accumulation of platelets and leuko-
cytes in the distal microvasculature of the brains of
human cases of CM, suggesting a role for platelet and leu-
kocyte sequestration in human CM pathology. However,
the role of chemokines and chemokine receptors in
malaria brain immunopathogenesis still remain unclear.
Recently, the up-regulated expression of RANTES and its
receptors (C CR3 and CCR5) in the cerebellar and cerebral
regions of post-mortem human CM brains has been
reported [8]. Additionally, others [9,10] have reported
increased migration of CCR5+ leukocytes into the brain in
experimental murine CM models. These studies support
the hypothesis that leukocyte recruitment by chemokines
may play a role in the pathogenesis of human CM.
Indeed, malaria has become one of the many inflamma-
tory diseases in which RANTES and its receptors appear to
play a role. RANTES, a chemokine involved in the genera-
tion of inflammatory infiltrates, plays a special role in the
maintenance and prolongation of the inflammatory
response. The trafficking of inflammatory Th1 cells into
the brain is mediated partly by RANTES interactions with
CCR5. RANTES binds to a variety of receptors including
CCR1, CCR3 and CCR5, expressed by monocytes/macro-
phages, memory T-cells, eosinophils, endothelial cells,
basophils and mast cells [11]. A comparative study using
Plasmodium berghei ANKA infected C57BL/6 and BALB/c
mice indicated th at both strains of mice expressed
CXCL10 (interferon-induced protein 10, IP-10) and CCL2
(monocyte chemotactic protein-1, MCP-1) chemokine
genes as early as 24 hours post-infection [12]. Moreover,
the expression of IP-10 and MCP-1 genes in KT5, an astro-
cyte cell line, was induced in vitro upon stimulation with
a crude antigen of malaria parasites [12]. Other more
recent studies, using malaria animal models, showed that
experimental cerebral malaria (ECM) was induced in per-
forin-deficient mice (PFP-/-) after adoptive transfer of cyto-
toxic CD8+ T cells from infected C57BL/6 mice, which
were directed to the brains of PFP-/-mice. This specific
recruitment involved chemokines and their receptors, and
indicated that lymphocyte cytotoxicity and trafficking are
key players in ECM [10]. While CCR2 was not observed to
be essential for the development of ECM [13], CCR5 defi-
ciency in mice reportedly decreased susceptibility to ECM
[9]. These studies, together, support the hypothesis that
leukocyte recruitment by chemokine and chemokine
receptor interactions play a role in the pathogenesis of
malaria in these animal models. It seems that plasmodial
infection has a significant impact on brain endothelial
and parenchymal cells and, thus, provides a new dimen-
sion to our understand ing of the role of systemic and
localized (brain) chemokine expression in CM immun-
opathogenesis. The cytoadherence of infected red blood
cells (IRBCs) to the postcapillary venules is the major
cause of IRBC sequestration and vessel blockage in the cer-
ebral form of human malaria. In both human cerebral
malaria caused by P. falciparum and the Plasmodium yoelii
17XL-infected rodent model of malaria, the sequestration
of IRBCs in the brain vessels is secondary to the cytoadher-
ence of IRBCs to the postcapillary venules [14]. In this
study, we analysed the alterations in immunomodulator
gene expression in brain samples of P. yoelii 17XL-infected
mice using cDNA microarray screening, coupled with
analysis of temporal expression patterns of RANTES and
its corresponding receptors, CCR1, CCR3 and CCR5, in
brain samples and plasma of P. yoelii 17XL-infected mice
to identify and characterize the role of these immu-
nomodulators during rodent malaria.
Methods
Murine model of P. yoelii 17XL malaria and preparation 
of brain samples
All animal-related experiments were conducted according
to the principles set forth in the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and
approved by the Institutional Animal Care and Use Com-
mittee (IACUC) of Morehouse School of Medicine.
Female Swiss Webster (SW) mice (6–8 weeks) obtained
from Jackson Laboratory (Bar Harbour, Maine, USA) were
maintained on a 12 hr light/dark cycle with access to foodMalaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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and water ad libitum, in accordance with IACUC regula-
tions of the Association for Assessment and Accreditation
of Laboratory Animal Care (AAALAC). Humane methods
were used to sedate mice prior to intra-peritoneal injec-
tion and tail-snipping. Briefly, the inhaled anesthetic
(0.1–0.2 ml isoflurane or halothane per liter of induction
chamber volume to give a gas concen tration of 2–4%,
required to induce anesthesia) were administered to the
female SW mice. The induction process was visualized
through the anesthetic chamber and the abolition of the
toe-pinch pain reflex assessed by applying pressure to
indicate the successful induction of anesthesia. Mice were
injected intraperitoneally with P. yoelii 17XL parasitized
blood, kindly provided by Dr. Christine Olver (Depart-
ment of Pathology, Colorado State University, USA). This
rodent malaria strain causes a syndrome that resembles
human malaria, char acterized by fever, spleno- and
hepatomegaly by day eight post-infection [14,15]. Parasi-
taemia was determined in a total count of 300 to 500 red
blood cells (RBCs) on Wright-Giemsa-stained (Sigma
Diagnostics, USA) thin blood smears. Euthanasia was
conducted by the inhalation of CO2 or cervical disloca-
tion, and groups of fifteen infected and uninfected mice
were sacrificed after day two, four, six and eight post-infec-
tion. For each time point, five brains from infected mice
were stored in RNA later (AmbionTM Inc., USA) at -80°C
for RNA isolation, five brains were stored in Lysis Buffer at
-80°C for protein analysis, and 5 were cryoprotected in
4% paraformaldehyde at 4°C for light and transmission
electron microscopy. Similarly, brains from uninfected
mice were stored for RNA isolation, protein analysis, and
light and transmission electron microscopy.
RNA isolation
Messenger RNA (mRNA) was isolated from brain samples
using TRIzol Reagent (Life Technologies Inc., Rockville,
MD., USA) according to the manufacturer's protocol.
Genomic DNA contamination was removed from these
samples by treatment with RNase-free DNase (Invitrogen,
San Diego, CA, USA) for 15 minutes at 37°C. RNA was
then precipitated and re-suspended in diethylpyrocarbon-
ated (DEPC)-treated water.
cDNA microarray screening
Five micrograms (5 µg) of DNA-free RNA from day 8 post-
infected (peak parasitaemia) mouse brain was reverse
transcribed, in the presence of 100 µCi of [alpha-32P]
dATP, for microarray analysis. The commercial system
used to investigate cDNA microarray gene expression
(AtlasTM 1.0; CLONTECH, Palo Alto, CA., USA) consists
of two identical nylon membranes, spotted with 588 dif-
ferent mouse genes grouped in functional blocks, includ-
ing immunomodulators, neurotrophins,
neurotransmitters and pro- and anti-apoptosis genes. A
complete list of the cDNA samples and controls on each
array, as well as their corresponding GenBank accession
numbers, may be found at CLONTECH's Atlas web site
http://www.clontech.com/clontech/atlas/index.shtml.
Briefly, [alpha-32P] dATP-labelled cDNA synthesized from
the 5 µg DNA-free RNA by reverse transcription was col-
umn purified and hybridized, at high stringency, to a
mouse cDNA array overnight at 70°C. Membranes were
washed at high stringency and exposed to X-ray film at -
80°C overnight, as recommended by the manufacturers.
Message expression was analysed using the AtlasTM Image
1.0 software (CLONTECH, Palo Alto, CA., USA) and the
data expressed as the ratios of the relative changes in the
mRNA levels in the infected brain samples and uninfected
controls. Expression of mRNA populations (from infected
and uninfected mice) at day 8 post-infection were com-
pared and analysed by autoradiography and quantified by
CLONTECH gene an alysis software. An approximate esti-
mate of the abundance level of a target cDNA in an RNA
population can be made by comparing its signal to the sig-
nals obtained with housekeeping genes of known abun-
dance (e.g. GAPDH).
RT-PCR validation of immunomodulator mRNA 
expression
Genes encoding induced RANTES, CCR1, CCR3 and
CCR5 were selectively confirmed by semi-quantitative RT-
PCR. Mouse mRNA sequences of RANTES, CCR1, CCR3,
CCR5 and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were obtained from the National Institute of
Health -National Center for Biotechnology Information
(NIH-NCBI) GeneBank database accession numbers
[AF_252285], [NM_009912], [NM_009914], [D_83648]
and [NM_008084] respectively. These sequences were
then used to design primers for RT-PCR analysis, which
generated amplicons of 97, 103, 96, 100, and 95 base
pairs in sizes for RANTES, CCR1, CCR3, CCR5 and
GAPDH mRNA respectively. Primers were designed using
the primer 3 software program from the Whitehead Insti-
tute at the Massachusetts Institute of Technology (MIT;
Boston, MA., USA). Thermodynamic analysis of the prim-
ers was conducted using computer programs: Primer Pre-
mier TM (Integrated DNA Technologies, Coralville, Iowa,
USA), and MIT Primer III (Boston, MA., USA). The result-
ing primer sets were compared against the entire mouse
genome using NCBI to confirm specificity and ensure that
the primers flanked mRNA splicing regions. Complemen-
tary DNA (cDNA) was generated (Maxim Biotech Inc.,
CA., USA), and amplified with specific primers using Taq
polymerase and polymerase chain reaction (PCR) rea-
gents (Qiagen Inc. Valencia, CA., USA). The levels of band
intensities of mRNA of these targets relative to GAPDH
were evaluated by PCR analysis using thermocycler (Per-
kin-Elmer, Norwalk, Conn., USA). Conditions for DNA
amplifications were set as follows: heating at 94°C for five
minutes, followed by 25 cycles of DNA denaturation atMalaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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94°C for one minute, an annealing step at X°C (see Table
1 for respective temperature values for each primer) for
one minute, strand exten sion at 72°C for one minute and
a final extension step at 72°C for 10 minutes. The number
of cycles required to attain products in the linear range of
the PCR was determined before the final assay was run.
Working within this range, it was possible to determine
expression differences after 25–30 cycles. PCR products
were analysed on 2%-agarose/ethidium-bromide gels and
quantified using Gelexpert software (NucleoTech, San
Mateo, CA, USA). Band intensities in each experiment
were normalized to the mean intensity of GAPDH. Data
were expressed as the relative change in mRNA level in
infected and uninfected controls.
Western blot analysis of RANTES
Western blot analysis was used to confirm RANTES pro-
tein expression in mouse brain during P. yoelii 17XL infec-
tion. Infected and uninfected mice brains were lysed and
their total protein determined by standard methods using
a commercial kit (BioRad, Hercules, CA, USA). Twenty
five micrograms (25 µg) of total protein from mouse
brain was subjected to 15% SDS-PAGE, and blo tted onto
nitrocellulose membranes. Membranes were then probed
with 1:1000 biotinylated anti-mouse recombinant
RANTES (R&D Systems, Inc. MN, USA) and 1:2000 anti-
mouse alpha-tubulin (Sigma-Aldrich, MO, USA) anti-
body. Membranes probed with biotinylated anti-mouse
recombinant RANTES were incubated with streptavidin-
horseradish peroxidase (HRP) secondary antibody while
those probed with alpha-tubulin were incubated with
anti-mouse IgG secondary antibody at the same condi-
tions. The methods used for pre-incubatio n, incubation
and detection by chemiluminescence have already been
described [16]. Bands of protein corresponding to RANT
ES (7.8 kDa) and alpha-tubulin (55 kDa) were quantified
using Versa Doc Imaging System (BioRad, CA, USA).
RANTES protein expression was normalized to that of
alpha-tubulin.
ELISA determination of plasma RANTES levels
To determine whether RANTES and its receptor interac-
tions were localized (brain) or systemic (peripheral
blood), plasma RANTES levels were determined in P. yoelii
17XL-infected and control mice, using RANTES specific
ELISA (Biosource International, Camarillo, CA, USA)
according to the manufacturer's specifications. Since
RANTES may be released by platelets during serum collec-
tion, heparinized blood was collected, centrifuged at
13,000 rpm for 10 minutes to obtain plasma samples, and
subsequently stored at -20°C until used. Briefly, dupli-
cates of standard controls, and samples were aliquoted
into RANTES-coated microtiter wells. Biotin-conjugated
antibody was added to the wells and incubated at room
temperature for 2 hours. Streptavidin-horseradish peroxi-
dase (Streptavidin -HRP) was then added to each well and
incubated at room temperature for 30 min. The plates
were developed with stabilized chromogen in the dark at
room temperature. The reaction was stopped and optical
densities of samples were read at 450 nm.
Histopathologic analysis of P. yoelii 17XL infected mouse 
brain
Whole brains of infected and uninfected mice at peak par-
asitaemia were examined by light microscopy to evaluate
erythrocytic and leucocytic sequestration in brain microv-
asculature. Whole mouse brains fixed in 4% paraformal-
dehyde were processed for routine histology, with
haematoxylin and eosin staining. Sections of these para-
formaldehyde-fixed samples (20 randomly selected sec-
tions of microvessels) from each brain were scored
positive or negative for erythrocyte and leukocyte seques-
tration. The percentages of microvessels from each brain
that showed erythrocytic and leucocytic sequestration
were noted.
Ultrastructural analysis of P. yoelii 17XL infected mouse 
brain
Whole brains of infected and uninfected mice at peak par-
asitaemia were examined by electron microscopy to eval-
uate parasite induced morphological changes in brain
microvasculature. Brains were dissected, cut into smaller
cubes (2 mm3), washed twice with phosphate buffered
saline (PBS) and fixed for 60 minutes in 100 mM potas-
sium phosphate buffer pH 7.2, containing 0.1 % gluteral-
dehyde and 2% freshly prepared formaldehyde. After
fixation the brains were dehydrated in methanol and
embedded in Lowicryl K4M at -20°C. Thin sections were
Table 1: Primer sequence with corresponding annealing temperatures
Mouse Gene GenBank Accession Number Sequence (Forward) Sequence (Reverse) Annealing Temp (°C)
RANTES AF252285 GGAAATCTTCGCACCTCAAG GAGCGTGCGAACTTCTTGTT 55
CCR1 NM009912 CCACTCCATGCCAAAAGACT ATTAGGACATTGCCCACCAC 50
CCR3 NM009914 TATCATTACCTGGGGCCTTG CGAGGACTGCAGGAAAACTC 53
CCR5 D83648 CGAAAACACATGGTCAAACG GTTCTCCTGTGGATCGGGTA 52
GAPDH NM_008084 CACAATTTCATCCCAGACC GTGGGTGCAGCGAACTTTAT 55Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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collected on 300-mesh nickel grids and examined by
transmission electron microscopy at 60 eV as described
previously [17].
Statistical analysis
The results obtained in this work were from triplicate
experiments performed independently by identical meth-
ods. ELISA data and densitometric measurements from
agarose gel electrophoresis, as well as Western blot analy-
ses, were log-transformed to normalize the distribution
for infected (n = 15) and control (n = 15) samples, and
also to correct for small sample size. Data were expressed
as the mean ± standard error of mean (SEM). Data from
the P. yoelii 17XL infected and control groups were then
compared, and the p values were determined by using
nonparametric Mann-Whitney U-test. A value of p < 0.05
was considered statistically significant.
Results
Plasmodium yoelii 17XL murine malaria
All the mice infected with P. yoelii 17XL parasites devel-
oped malaria-related-symptoms, which included the
appearance of ruffled fur and shivering at peak parasitae-
mia by day eight post-infection (Figure 1). Examination of
the viscera of dissected mice confirmed spleno- and
hepatomegaly at peak parasitaemia, concordant with
reported P. yoelii 17XL malaria infections [14,15]. None of
the control or uninfected mice showed any of these signs.
T he mice infected with P. yoelii 17XL did not develop the
classic signs of cerebral pathology (such as hemiplegia,
paraplegia, ataxia with hind limb paralysis, convulsions
and coma associated with murine CM previously
described in the Plasmodium berghei ANKA murine CM
model [18,19]). Additionally, histopathologic analysis of
brains of the P. yoelii 17XL-infected mice revealed plug-
ging of brain microvessels with parasitized erythrocytes,
but d id not reveal evidence of disseminated petechial
haemorrhages and extensive leukocyte accumulation in
the microcirculation. However, there was ultrastructural
evidence of oedema and disintegrating microvascular
endothelia in the cerebellum, which reflect local perturba-
tions induced by the P. yoelii 17XL infection.
cDNA microarray screening
P. yoelii 17XL-attributable alterations in approximately
7.5% (44/588) of genes encoding immunomodulators,
growth factors, stress factors, transcription factors and
neurotransmitters were observed in infected mouse brain
during the microarray analysis. Expression of the altered
genes at peak parasitaemia in the infected mice varied
when compared with that in the uninfected mice (Figure
2). Marked alterations in expressio n of immunomodula-
tor mRNA, including C-C chemokine RANTES, C-C chem-
okine receptors CCR1, CCR3 and CCR5, adhesion
molecules PECAM-1, ICAM-1, and VCAM-1, cytokines IF
N-gamma, TNF-alpha, IL-12, IL-4, and iNOS were
observed to be up-regulated, while growth factors, GDF-2
and TGF-beta precursor, were down-regulated (Table 2, P
< 0.05) at peak parasitaemia.
RT-PCR validation of immunomodulator mRNA 
expression
The expression of RANTES and its corresponding recep-
tors, CCR1, CCR3 and CCR 5, were altered by P. yoelii
17XL infection and were significantly up-regulated (p <
0.002 for RANTES, p < 0.036 for CCR1, p < 0.033 for
CCR3 and p < 0.026 for CCR5) in the brain during
malaria infection. Up-regulation of RANTES mRNA began
four days after infection, until eight days post-infectio n,
approximately three-fold increase in infected mouse brain
at day six and day eight post-infection compared with
controls [Figure 3A]. Messenger RNA expression levels of
CCR1, CCR3 and CCR5 were approximately two to three
fold higher in infected mice than in controls [Figures 3B,
3C &3D]. CCR3 and CCR5 expression profiles were simi-
lar to the expression profile of their corresponding
RANTES ligand. The degree of variation of GAPDH mRNA
from sample to sample was within 5% of the mean expres-
sion level in both infected and uninfec ted control sam-
ples throughout the course of the infection.
Course of P. yoelii 17XL infection in female SW mice Figure 1
Course of P. yoelii 17XL infection in female SW mice. 
Level of parasitaemia in P. yoelii 17XL infected mice was 
monitored from the tail vein blood and counting at least 300 
RBCs under immersion oil. Data represent mean ± SEM of 
5–10 counts per point.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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Western blot analysis
Results from the Western blots analysis indicated that the
expression of RANTES (7.8 kDa) protein in brain tissue
samples from infected mice at day four, six and eight post-
infection, was significantly up-regulated (p = 0.049 at day
four and p < 0.036 at day six and day eight) [Figure 4A].
Expression of RANTES protein in brain tissues followed a
similar profile consistent with mRNA expression indicat-
ing that RANTES mRNA expression in brains of P. yoelii
17XL infected mice were translated into protein. Expres-
sion of alpha-tubulin protein from sample to sample was
within 5% of the mean expression level in both infected
and uninfected samples throughout the course of the
infection.
Plasma RANTES protein level during P. yoelii 17XL 
infection
Plasma samples from infected mice at each time point as
well as uninfected controls were assayed for RANTES pro-
tein expression. Systemic increase in RANTES protein
expression began four days after P. yoelii 17XL infection,
until peak parasitaemia at day eight with about three-fold
upregulation in infected plasma compared with control
[Figure 4B].
Histopathologic analysis of mouse brain
Sequestered parasitized erythrocytes were observed in
brain microvessels of all the P. yoelii 17XL-infected mice
studied at peak parasitaemia, but none of the uninfected
mice. There was no histopathologic evidence of seques-
tered or accumulated mononuclear leukocytes (mono-
Autoradiograph of cDNA microarray of P. yoelii 17XL infected and uninfected control mice brains Figure 2
Autoradiograph of cDNA microarray of P. yoelii 17XL infected and uninfected control mice brains. Arrows indi-
cate some differences in intensity in expression of im munomodulator gene expression between P. yoelii 17XL infected and 
control mice brains.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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cytes/macrophages and lymphocytes) or extensive
petechial haemorrhages in the brains of both the infected
and uninfected mice. In the brain of the infected mice, the
erythrocyte sequestration observed in the white and grey
matter regions was identical.
Ultrastructural analysis of mouse brain
Brains from parasitized mice were ultrastructurally ana-
lysed by transmission electron microscopy to evaluate
effects of P. yoelii 17XL infection on brain microvessel
endothelium. Uninfected mouse cerebellar tissues (Mag.
× 15000) showed normal intact microvessel endothelia
(ME) at blood b rain barrier (BBB). Infected mouse cere-
bellar tissues (Mag. × 15000) showed peri-vascular clear-
ing concomitant with oedema as well as some
disintegrating ME and BBB [Figure 5]. This endothelial
cell damage (lesions) was observed in 6 out of 10 mice
examined at day eight post-infection. Erythrocytic (RBC)
adherence in the microvessels, but not leukocytic (WBC)
adherence, was observed in the infected mouse brains
examined.
Discussion
The brain pathology associated with malaria remains a
major cause of death d uring severe P. falciparum infection.
Cerebral malaria, characterized by coma and seizures in
patients with P. falciparum infection, is a major cause of
malaria associated mortality, and may be accompanied by
metabolic acidosis and hypoglycaemia in African children
[20]. Using experimental models will facilitate a better
understanding of the pathogenesis of this syndrome and
therefore ensuring that better intervention strategies can
be developed to minimize or abrogate the severity of the
disease. The cytoadherence of infected red blood cells
(IRBCs) to the postcapillary venules is the major cause of
IRBC sequestration and vessel blockage in the cerebral
form of human malaria. In both human cerebral malaria
caused by P. falciparum and the P. yoelii 17XL-infected
rodent model of malaria, the sequestration of IRBCs in the
brain vessels is secondary to the cytoadherence of IRBCs
to the postcapillary venules [14,15]. This observation has
resulted in the general suggestion that the P. yoelii 17XL
mouse model resembles human P. falciparum infection
more closely than the P. berghei ANKA mouse model,
since it shows little accumulation of monocytes /macro-
phages in the brain microvessels [14,15]. However, recent
human CM studies [4-7], indicating significant ac cumu-
lation of platelets and leukocytes in the distal cerebral
microvasculature in CM, suggest some other similarities
between human CM and the P. berghei ANKA mouse CM
model, in addition to the similarities in symptomatology
[18,19]. These recent reports [4-7] of significant leukocyte
accumulations in the brain microvasculature in human
CM draws a similarity with the P. berghei ANKA-infected
rodent model of malaria, in which the major histopatho-
logic finding is extensive accumulation of monocytes or
macrophages, rather than sequestered erythrocytes, in the
brain [18,19].
In this study, all the mice infected with P. yoelii 17XL
developed malaria-related symptoms, which included the
appearance of ruffled fur and shivering by peak parasitae-
Table 2: cDNA microarray analysis of immunomodulator gene expression in P. yoelii 17XL infected mouse brain at peak parasitemia 
(day eight post-infection).
GENE NAME FOLD CHANGE EXPRESSION DESCRIPTION OF GENE
PECAM-1 23.0 Platelet Endothelia Cell Adhesion Molecule-1
ICAM-1 13.0 Intercellular Adhesion Molecule-1
VCAM-1 6.0 Vascular Cell Adhesion Molecule-1
RANTES 6.0 Regulated upon Activation Normal T cell Expressed and Secreted
INF-γ 6.0 Interferon-gamma
TNF 5.0 Tumor Necrosis Factor-alpha
IL-12 4.0 Interleukin-12
CCR1 4.0 C-C chemokine receptor 1
CCR3 4.0 C-C chemokine receptor 3
CCR5 4.0 C-C chemokine receptor 5
iNOS 4.0 Inducible Nitric Oxide Synthase
ZO-1 2.0 Zonula Occludin -1
IL-4 2.0 Interleukin-4
GDF-2 -2.0 Growth differentiation factor-2
TGF-α -2.0 Tumor growth factor-alpha
GAPDH 0.0 Glyceraldehyde-3-Phosphate Dehydrogenase
P. yoelii 17XL infection alters immunomudulator gene expression in mouse brain at peak parasitemia (day eight post-infection). cDNA microarray 
analysis of P. yoelii 17XL infected and uninfected mouse brain. Gene listed were altered > 1.5 fold at peak parasitemia. Fold change in expression is 
defined as GAPDH normalized mRNA expression ratio of gene signals of infected to uninfected mouse brain.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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mia at day eight post-infection. Spleno- and hepato-meg-
aly at peak parasitaemia was common, and concordant
with reported P. yoelii 17XL malaria infections [14,15].
The observation of the absence of the classic signs of cere-
bral pathology in the P. yoelii 17XL-infected mice at peak
parasitaemia and the histopathologic findings of IRBC
sequestration and vessel plugging with the absence of leu-
cocyte accumulation in brains of P. yoelii 17XL-infected
mice, confirms previously reported observations [14,15].
The classic signs of cerebral pathology, namely hemiple-
gia, paraplegia, ataxia with hind-limb paralysis, convul-
sions and coma, have been previously described in the P.
berghei ANKA mouse model [18,19]. These observations
provide a justification for the complementary use of both
murine malaria models to study human CM. The P.
berghei ANKA model shows similarity with human CM in
terms of symptomatology, whilst the P. yoelii 17XL model
exhibits similarity to human CM in terms of histopathol-
ogy. This study focused mainly on malaria induced chem-
okine and chemokine receptor expression in the P. yoelii
17XL murine model. Animal models have provided com-
pelling evidence implicating the role of inflammatory
processes in the development of malaria brain pathology
[21]. Adhesion molecules and platelet-induced immune-
mediated damage of vascular endothelium of the brain
have also been reported [21]. Tkachuk and colleagues
P. yoelii 17XL upregulates RANTES, CCR1, CCR3 and CCR5 mRNA expression in mouse brain Figure 3
P. yoelii 17XL upregulates RANTES, CCR1, CCR3 and CCR5 mRNA expression in mouse brain. Semi-quantita-
tive RT-PCR comparative analysis of RANTES CCR1, CCR3 and CCR5 mRNA expressions in brains of P. yoelii 17XL-infected 
(I, black bars) days two, four, six, and eight post-infections and control (C, grey bars) mice. Densitometric data presented were 
log-transformed (to adjust for small sample size) and represent the mean and ± SEM of infected (n = 5) and control (n = 5) 
cases, normalized to those for GAPDH. Asterisk(s) indicate statistically significant differences between P. yoelii 17XL infected 
and control groups.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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observed that malaria infection induced the expression of
CCR3 and CCR5 on placental macrophages in pregnant
women [22]. Sarfo and colleagues indicated that RANTES
and its receptors CCR3 and CCR5 were upregulated in the
cerebellum and cerebrum of post-mortem human CM tis-
sue samples [8]. Furthermore, activated T-lymphocytes,
platelets and endothelial cells release large amount of
RANTES 3–5 days after activation, giving this chemokine
a unique role in the generation, maintenance and prolon-
gation of immune and inflammatory response [23]. By
understanding the role of RANTES and its receptors dur-
ing malaria immunopathogenesis, a new strategy for pre-
venting or minimizing the outcome of CM and other
severe forms of malaria can be developed. The microarray
results (Table 2) confirmed with semi-quantitative RT-
PCR analysis from this study revealed changes in the
expression of a number of immunomodulators that had
previo usly been associated with malaria-induced brain
dysfunction [12]. In this study, the expressions of RANTES
and its corresponding receptors CCR1, CCR3 and CCR 5
were up-regulated in the brain during P. yoelii 17XL infec-
tion, further implicating these molecules in the pathogen-
esis of rodent cerebral malaria. This study is a first towards
the development of a molecular fingerprint (diagnostic)
for brain immunopathogenesis associated with malaria.
In this regard, recent studies with infectious agents such as
Salmonella,  Chlamydia  and  Trypanosoma  using cDNA
microarray technology have revealed unique gene-expres-
sion profiles [24-26] which may be of diagnostic value.
This study demonstrates that chemokine RANTES (CCL5)
and its receptors (CCR1, CCR3 and CCR5) may play an
important role in P. yoelii 17XL infection in mice. Chem-
okines are immunoregulatory factors that play an impor-
tant role in the chemotaxis, activation and
haematopoiesis of leukocytes [27-29]. Chemokine action
P. yoelii 17XL infection upregulates RANTES protein expression in plasma and mouse brain Figure 4
P. yoelii 17XL infection upregulates RANTES protein expression in plasma and mouse brain. Comparative analy-
sis of RANTES (7.8 kDa) protein expression in brain tissue samples (A) and plasma (B) from P. yoelii 17XL-infected mice days 
two, four, six, & eight post-infection (black bars) versus uninfected controls (grey bars). Brain tissue protein and plasma sam-
ples from infected and uninfected mice were analysed for RANTES expression by Western Blot and ELISA respectively. Densi-
tometric data of Western blots were log-transformed (to adjust for small sample size) and represent the mean and ± SEM of 
infected (n = 5) and control (n = 5) cases, normalized to those for atubulin. Asterisk(s) indicate statistically significant differ-
ences between P. yoelii 17XL-infected and control groups.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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involves initial binding to specific, seven-transmembrane-
domain, G-(guanine-nucleotide-binding)-protein-cou-
pled receptors on target cells. In response to a relatively
higher concentration of chemokines at the site of injury or
infection, leukocytes are activated to perform effector
functions such as release of their granule contents and
increased production of cytokines. The temporal expres-
sion profile of chemokines and their receptors as early
immunomodulators in the immunopathogenesis of
malaria could serve as important new bio-markers for
monitoring the course and predicting the outcome of the
disease. The cDNA microarray analysis has revealed signif-
icant up-regulation of RANTES (6fold) at peak parasitae-
mia. The results of RT-PCR analysis indicate that by days
6 through 8 post-infection, mRNA expression of RANTES
is significantly up-regulated (p < 0.002) in infected mice
compared with controls, indicating that it is involved in
the immunopathogenesis in P. yoelii 17XL-infected
mouse. RANTES in addition to CCR1 and CCR5 are
expressed by Th1 cells [30]. Indeed, trafficking of inflam-
matory Th1 cells into the brain was reportedly mediated
largely by RANTES interaction with CCR5 receptor [30].
Also the absence of CCR5 receptor in Plasmodium berghei
ANKA-infected mouse brain resulted in a reduced Th1
cytokine production [9]. The expression of RANTES and
CCR5 mRNA in P. yoelii 17XL-infected mouse brain in this
study suggests a Th1-mediated immune response, and
that factors capable of inducing Th1 response could play
an important role in modulating malaria infections. Mac-
rophages and other leukocytes release proinflammatory
cytokines, including TNF-alpha, IFN-gamma and IL-1-
beta, which in turn will promote the release of chemok-
ines [30]. The expression of chemokine, IP-10 and MCP-
1, genes in KT-5, an astrocyte cell line, have been shown
to be upregulated in vitro upon stimulation with a crude
antigen of malaria parasites [12]. A soluble gradient of
P. yoelii 17XL induces ultra structural changes in mouse cerebellum at peak parasitaemia (day eight post-infection) [scale bar: 1  µm] Figure 5
P. yoelii 17XL induces ultra structural changes in mouse cerebellum at peak parasitaemia (day eight post-infec-
tion) [scale bar: 1 µm]. Cerebellum from parasitized mice was ultra structurally analysed by transmission electron micros-
copy to evaluate effects of P. yoelii 17XL infection on brain micro vessels. Uninfected mice (Mag. × 15000) show normal intact 
micro vessel endothelia (ME) at blood brain barrier (BBB). Infected mice (six out of 10) [Mag. × 15000] show disintegrating ME 
and BBB (arrow) of brain vessels examined at day eight post-infection. Erythrocytic (RBC) adherence in the microvessels, but 
not leukocytic (WBC) adherence, was observed in the infected mouse brains examined.Malaria Journal 2005, 4:63 http://www.malariajournal.com/content/4/1/63
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these chemokines within the tissue recruits various cell
types that express receptors for the different chemokines.
The expressions of all the C-C chemokine receptors for
RANTES, CCR1, CCR3 and CCR5, were upregulated in the
brains of P. yoelii 17XL-infected mice. The expression of
RANTES probably enhanced the expression of its recep-
tors. Sano and colleagues demonstrated that ICAM-1
induced RANTES mRNA expression and also increased its
protein synthesis and secretion by endothelial cells [31].
It is likely that the P. yoelii 17XL-induced RANTES produc-
tion observed in the current study would attract and acti-
vate leukocytes towards inflammatory sites to mediate
localized hyper-inflammatory responses that could exac-
erbate the disease pathology in the cerebellum. Belnoue
and colleagues showed that the brains of wild -type mice
with CM have significantly higher levels of CCR5 than the
knockout-type, implicating these molecules in the patho-
logical changes produced in the brain during the infection
[9]. The results of this study demonstrate that the increase
in production of RANTES follows the course of P. yoelii
17XL malaria infection, thus RANTES and its receptors
CCR1, CCR3 and CCR5 were detected at their highest lev-
els at day six and day eight post-infection. This observed
temporal association of the progression of P. yoelii 17XL
infection with the increasing production of RANTES and
its receptors suggests that the two events might be linked.
Western blot analysis revealed that brain tissue transcripts
of RANTES were actually translated into protein, and were
significantly up-regulated (p = 0.046 for day 4 and p <
0.034 for day six and day eight post-infection) in infected
mice (Figure 3A). The ELISA data from this study indicate
significant upregulation (p = 0.049 for day 4 and p <
0.026 for day six and day eight post-infection) of RANTES
in P. yoelii 17XL-infected mouse plasma than in controls
(Figure 3B). Most of the ultrastructural pathological
changes, observed as endothelial cell damage (lesions) in
six out of the 10 infected mice examined, occurred espe-
cially at day eight post-infection (peak parasitaemia) [Fig-
ure 5]. Thus, the increase in RANTES production
correlated with the increase in parasitaemia and patholog-
ical changes observed in the P. yoelii 17XL-infected mice in
this investigation. Chemokines have been shown to have
a direct antiprotozoal activity for three protozoans: Toxo-
plasma gondii, Leishmania donovani and Trypanosoma cruzi
[32,33]. Chemokine production is important for defend-
ing the host against infection. However, excessive produc-
tion is also deleterious to the host [12]. It has been
observed that C-C chemokines, such as MIP-1-alpha and
RANTES, are significantly upregulated in brains of
Trypanosoma brucei brucei infected rats [34]. This increase
in expression of these chemokines occurs before brain
lesions developed in infected rats, implying that the
induction of these chemokines could be directly responsi-
ble for the observed rat brain lesions [34]. Ultrastructural
analysis of mouse brain by electron microscopy at peak
parasitaemia in this study, revealed disintegrating microv-
ascular endothelial layer at the blood brain barrier in the
cerebellar region of infected mouse brain. This endothelia
l cell damage (lesions), in six out of 10 mice examined,
occurred especially at day eight post-infection (peak para-
sitaemia) and was similar to the observations of Thum-
wood and colleagues in P. berghei ANKA-infected A/J and
CBA/H mice [35]. The infected erythrocytes adhering and
occluding brain microvessels observed in the sections
examined, suggest that the breach in the cerebellar micro-
vascular endothelial layer could be associated with para-
site-induced inflammation or apoptosis. Perivascular
oedema was also observed in this region of infected
mouse brain probably as a result of the endothelial cell
damage allowing excess fluid to move across the blood
brain barrier. End othelial cells interacting with P. yoelii
17XL-parasitized erythrocytes have been shown to be
induced to produce and present specific chemokines, such
as RANTES, which can lure CCR1, CCR3 and CCR5
expressing cells into the brain [36]. CCR1 and CCR 5 are
exp ressed by brain endothelial cells [37,38]. Brain
endothelial cells, microglia and astrocytes, which are the
3 major cellular components of the BBB, express CCR5
receptor [39], and hence the binding of RANTES to its
receptors on these cells can serve to further activate them
and enhance a localized breakdown of the microvessel
endothelial layer observed in the infected mouse brain in
the current investigation.
Conclusion
In conclusion, P. yoelii 17XL infection upregulates
RANTES and its corresponding receptors, CCR1, CCR3
and CCR5, in mouse brain, and that ultrastructural
changes in the microvascular endothelial layer occurred in
the cerebellum of infected mice. This is the first temporal
expression study of RANTES and its receptors associated
with murine malaria. Further studies are underway to
examine the expression of these chemokines and chemok-
ine receptors in a human CM symptomatology-like model
such as P. berghei ANKA, to ascertain differences and sim-
ilarities. As it is not clear which cell types in the mouse CM
brain samples over-express RANTES, CCR1, CCR3 and
CCR5, further comparative immunolocalization and anti-
body ablation studies are currently underway to examine
the physiological relevance, source and expression pat-
terns of these important biomarkers in both murine and
human CM brain samples.
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